Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 21.1% during trading on Friday . The stock traded as high as C$0.12 and last traded at C$0.12. 710,813 shares changed hands during trading, an increase of 344% from the average session volume of 160,239 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The company has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s 50-day moving average is C$0.08 and its 200 day moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What is the Hang Seng index?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Most active stocks: Dollar volume vs share volume
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
